| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 46,109 | 46,076 | 42,700 | 38,396 | | Cost of Revenue | 11,800 | 13,657 | 14,258 | 21,544 | | | Gross Profit | 34,309 | 32,419 | 28,442 | 16,852 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,856 | 9,491 | 14,387 | 10,166 | | Non Recurring | 5,699 | 2,652 | 3,928 | 127,357 | | Others | 31,609 | 35,897 | 33,974 | 19,649 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (11,855) | (15,621) | (23,847) | (140,320) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 30,247 | (914) | 3,689 | 19,051 | | Earnings Before Interest And Taxes | 18,392 | (16,535) | (20,158) | (121,269) | | Interest Expense | 1,576 | 4,524 | 11,713 | 12,058 | | Income Before Tax | 16,816 | (21,059) | (31,871) | (133,327) | | Income Tax Expense | (12,602) | 12,602 |
-
| (40,359) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 32,084 | (33,661) | (31,871) | (92,968) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 29,418 | (33,661) | (31,871) | (92,968) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $29,418 | ($33,661) | ($31,871) | ($92,968) |
|
0.51% Nasdaq 
Income Statement
